SG192845A1 - Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer - Google Patents

Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer Download PDF

Info

Publication number
SG192845A1
SG192845A1 SG2013062864A SG2013062864A SG192845A1 SG 192845 A1 SG192845 A1 SG 192845A1 SG 2013062864 A SG2013062864 A SG 2013062864A SG 2013062864 A SG2013062864 A SG 2013062864A SG 192845 A1 SG192845 A1 SG 192845A1
Authority
SG
Singapore
Prior art keywords
sucrose
matrix
pharmaceutical composition
weight
fatty acid
Prior art date
Application number
SG2013062864A
Other languages
English (en)
Inventor
Diana Shu-Lian Chow
Roland A Ako
Je Phil Ryoo
Chun Kwong Chu
Zheng Wang
Original Assignee
Nal Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nal Pharmaceuticals Ltd filed Critical Nal Pharmaceuticals Ltd
Publication of SG192845A1 publication Critical patent/SG192845A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG2013062864A 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer SG192845A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/040,143 US8900634B2 (en) 2008-11-03 2011-03-03 Diethylstilbestrol dosage form and methods of treatment using thereof
PCT/GB2012/050475 WO2012117257A1 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Publications (1)

Publication Number Publication Date
SG192845A1 true SG192845A1 (en) 2013-09-30

Family

ID=45841525

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013062864A SG192845A1 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Country Status (13)

Country Link
US (1) US8900634B2 (enExample)
EP (1) EP2680813B1 (enExample)
JP (2) JP6059153B2 (enExample)
KR (1) KR101865776B1 (enExample)
CN (1) CN103561720A (enExample)
AU (2) AU2012223023B2 (enExample)
BR (1) BR112013022438A2 (enExample)
CA (1) CA2827892C (enExample)
ES (1) ES2733282T3 (enExample)
RU (1) RU2602296C2 (enExample)
SG (1) SG192845A1 (enExample)
TW (1) TWI548426B (enExample)
WO (1) WO2012117257A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
BR112015008367A2 (pt) 2012-10-15 2017-07-04 Chamaeleo Pharma Bvba fosfestrol para uso no tratamento curativo ou paliativo de câncer de próstata
EP2906223A1 (en) * 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Fosfestrol for use in curative or palliative treatment of cancer in female mammals
EP2906206A1 (en) * 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Sulfestrol for treating cancer
AU2015280262B2 (en) 2014-06-24 2020-08-13 Taho Pharmaceuticals Ltd. Fast acting orally disintegrating film
CN105997857A (zh) * 2016-06-29 2016-10-12 冯志清 一种用于治疗猪乳房炎的注射液
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR101940401B1 (ko) * 2017-06-12 2019-01-21 경상대학교산학협력단 맛이 차폐된 구강붕해필름 및 이의 제조방법
WO2019028457A2 (en) * 2017-08-04 2019-02-07 University Of Houston System FORMULATION OF NANOSUSPENSION OF DIETHYLSTILBESTROL INJECTABLE
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113133983B (zh) * 2020-01-20 2023-12-12 鲁南制药集团股份有限公司 一种治疗前列腺癌的药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
WO1999059544A2 (en) 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US20030147936A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Prostatic hormonal implants treatment of prostate cancer
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
WO2008045461A2 (en) 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
CA2682752C (en) * 2007-04-05 2015-07-07 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
WO2009029543A1 (en) 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof

Also Published As

Publication number Publication date
KR20140021587A (ko) 2014-02-20
ES2733282T3 (es) 2019-11-28
CA2827892C (en) 2019-12-03
CA2827892A1 (en) 2012-09-07
TW201249484A (en) 2012-12-16
AU2012223023B2 (en) 2017-03-16
JP2017061465A (ja) 2017-03-30
JP2014506914A (ja) 2014-03-20
KR101865776B1 (ko) 2018-06-08
US20110189288A1 (en) 2011-08-04
AU2017203009B2 (en) 2018-07-19
US8900634B2 (en) 2014-12-02
AU2017203009A1 (en) 2017-05-25
CN103561720A (zh) 2014-02-05
EP2680813B1 (en) 2019-05-08
TWI548426B (zh) 2016-09-11
JP6059153B2 (ja) 2017-01-11
EP2680813A1 (en) 2014-01-08
WO2012117257A8 (en) 2013-09-19
RU2602296C2 (ru) 2016-11-20
BR112013022438A2 (pt) 2016-12-06
WO2012117257A1 (en) 2012-09-07
RU2013144383A (ru) 2015-04-10
AU2012223023A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
AU2017203009B2 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
US20240122846A1 (en) Pharmaceutical composition comprising an androgen receptor inhibitor
JP2003055203A (ja) ユビキノン含有製剤
KR101360526B1 (ko) 개선된 약력학적 특성을 갖는 약물 제형
US20160058866A1 (en) Alternative solutions for the administration of cannabis derived botanical products
EP3419671B1 (en) High bioavailability oromucosal pharmaceutical preparations based on cyclodextrin and sucralose
US9168229B2 (en) Soft gelatin capsules
WO2009069139A1 (en) Dosage form providing an ibuprofen-containing liquid fill
AU2013346766B2 (en) Effervescent tablet
US20220211661A1 (en) Green tea catechins eutectic system
CN114681432B (zh) 一种丁苯酞组合物及其用途
HK1192153A (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
CN105169409A (zh) 普萘洛尔或其可药用盐与离子交换树脂的复合物及其混悬液
JP2020533369A (ja) チモキノン含有組成物の調製法
CN120605262A (zh) 辅酶q10口溶膜
CN118252797A (zh) 一种布地奈德黏性口服溶液、制备方法及其应用
Kar¹ et al. Current Developments in Excipient Science: Implication of Quantitative Selection of Each Excipient in